Test ID: CYPSP
21-Hydroxylase Gene (CYP21A2), Full Gene Analysis
Method Description
Describes how the test is performed and provides a method-specific reference
Four sets of primer pairs amplify all possible recombinant forms of CYP21A2, CYP21A1P (the pseudogene), and their hybrids 5'-CYP21A2/CYP21A1P-3' and 5'-CYP21A1P/CYP21A2-3' via PCR to determine whether there are large rearrangements between the gene and pseudogene. Fluorescent DNA sequence analysis is then performed on all exons of the active form of CYP21A2 and any presumed active hybrid to test for the presence of sequencing mutations (GenBank accession numbers: NM_000500.5). If necessary, further analysis may be performed on nonexpressed copies of CYP21A2 or hybrids to gain insight into possible rearrangements.(Cradic, KW, Grebe, SK: A Diagnostic Sequencing Assay for Cyp21 Based on Promoter Activity Provides Better Understanding of Gene Rearrangements. Abstract. Endocrine Society Annual Meeting, ENDO 2005)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday; 8 a.m.


